An Exploratory Study of ctDNA-MRD in Predicting the Efficacy of Esophageal Squamous Cell Carcinoma

Not yet recruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

March 31, 2023

Primary Completion Date

March 31, 2026

Study Completion Date

December 31, 2026

Conditions

Squamous Cell Carcinoma of Esophagus

All Listed Sponsors

lead

Guangzhou Institute of Respiratory Disease

OTHER

NCT05759325 - An Exploratory Study of ctDNA-MRD in Predicting the Efficacy of Esophageal Squamous Cell Carcinoma | Biotech Hunter | Biotech Hunter